Skip to main content

Closed

BBLG: Bone Biologics Corporation Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-64.3%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio16.09×

Bone Biologics Corporation

BBLGNASDAQ Capital Market·USD·Closed

Bone Biologics Corporation

BBLGNASDAQ·USD·Closed

$0.85

−1.67%

$0.85

−$0.01 (1.67%)

52W Range

0thpctl

Volume

0.31×avg

Mkt Cap

1.53MUSD

P/E

-0.5TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.31×avg

Market Cap

1.53MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings